🟢 PJP is trading 4.63% up in pre-market

PJP is trading at $132.54, up 4.63% in pre-market on October 29, 2026, with no confirmed direct catalyst in available reporting.

• PJP is a diversified pharmaceuticals ETF, not an individual drugmaker.
• Major holdings Merck, Eli Lilly, and Gilead are scheduled to report earnings on October 29; that calendar alone does not establish the reason for the gain.
• Supplied market indicators are mixed, and broader-market sentiment does not clearly explain the move.